본문 바로가기
KERD
논문KCI 등재

Clinical Features of Respiratory Syncytial Virus Infection in Neonates: A Single Center Study

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Purpose: The aim of this study was to investigate the clinical characteristics of Respiratory syncytial virus (RSV) infection during the neonatal period to provide information that is useful in clinical practice and suggest extension of the palivizumab administration. Methods: Neonates admitted to the National Health Insurance Service Ilsan Hospital neonatal intensive care unit due to respiratory symptoms and for whom multiplex reverse transcription-polymerase chain reaction and multiplex real time-polymerase chain reaction tests were performed between October 2011 and May 2016 were included in this study. Medical records were retrospectively reviewed, and data was collected for 156 neonates. Results: Among the 156 neonates, RSV was detected in 114 (73.1%), non-RSV in 25 (16%), and no virus in 17 (10.9%). The majority were full term infants (92.4%) and peak incidence of RSV infection was in January. Post-natal care center infection was more common in the RSV group (46.6%) than that in the other virus groups (24%, P= 0.0243). Clinical symptoms were severe in the RSV group in contrast to that in the non-RSV or others groups. The RSV group frequently needed oxygen therapy (P= 0.0001) and the duration of hospital stays were longer (P=0.0001). Conclusion: RSV is a significant cause of respiratory infection in neonates and the severity is higher in contrast to that with other viral causes of infection. Infants in post-natal care centers have a high-risk of developing RSV infections; therefore, palivizumab administration may be considered in this group to prevent hospitalization and reduce the duration of hospital stay.

Abstract

Purpose: The aim of this study was to investigate the clinical characteristics of Respiratory syncytial virus (RSV) infection during the neonatal period to provide information that is useful in clinical practice and suggest extension of the palivizumab administration. Methods: Neonates admitted to the National Health Insurance Service Ilsan Hospital neonatal intensive care unit due to respiratory symptoms and for whom multiplex reverse transcription-polymerase chain reaction and multiplex real time-polymerase chain reaction tests were performed between October 2011 and May 2016 were included in this study. Medical records were retrospectively reviewed, and data was collected for 156 neonates. Results: Among the 156 neonates, RSV was detected in 114 (73.1%), non-RSV in 25 (16%), and no virus in 17 (10.9%). The majority were full term infants (92.4%) and peak incidence of RSV infection was in January. Post-natal care center infection was more common in the RSV group (46.6%) than that in the other virus groups (24%, P= 0.0243). Clinical symptoms were severe in the RSV group in contrast to that in the non-RSV or others groups. The RSV group frequently needed oxygen therapy (P= 0.0001) and the duration of hospital stays were longer (P=0.0001). Conclusion: RSV is a significant cause of respiratory infection in neonates and the severity is higher in contrast to that with other viral causes of infection. Infants in post-natal care centers have a high-risk of developing RSV infections; therefore, palivizumab administration may be considered in this group to prevent hospitalization and reduce the duration of hospital stay.

참고문헌 (36)

  1. Shay DK, "Bronchiolitis-associated hospitalizations among US children, 1980-1996", JAMA, 282, pp.1440~1446 (1999)
  2. Choi EH, "The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005", Clin Infect Dis, 43, pp.585~592 (2006)
  3. Meert K, "Does prematurity alter the course of respiratory syncytial virus infection", Crit Care Med, 18, pp.1357~1359 (1990)
  4. Resch B, "The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years", Infection, 30, pp.193~197 (2002)
  5. Pedersen O, "Rehospitalization for respiratory syncytial virus infection in infants with extremely low gestational age or birthweight in Denmark", Acta Paediatr, 92, pp.240~242 (2003)
  6. Cardenas S, "Palivizumab in the prophylaxis of respiratory syncytial virus infection", Expert Rev Anti Infect Ther, 3, pp.719~726 (2005)
  7. Alan S, "Outcome of the respiratory syncytial virus related acute lower respiratory tract infection among hospitalized newborns: a prospective multicenter study", J Matern Fetal Neonatal Med, 29, pp.2186~2193 (2016)
  8. Hall CB, "Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age", Pediatrics, 132, pp.e341~e348 (2013)
  9. Woo Sun Song, "Clinical Characteristics of Acute Respiratory Tract Infections in Full-Term Newborns without Risk Factors", Neonatal medicine, 22(1), pp.27~33 (2015), 대한신생아학회
  10. 윤가현, "호흡기세포융합 바이러스 아형에 따른 영아기 폐렴 및 모세기관지염의 임상 양상: 2010.2012 일개 삼차병원의 경험", Allergy Asthma & Respiratory Disease, 1(1), pp.84~89 (2013), 대한 소아알레르기 호흡기학회
  11. 서진종, "광주지역 소아에서 유행한 호흡기바이러스 유행양상 분석", Infection and Chemotherapy, 40(4), pp.218~229 (2008), 대한감염학회
  12. 김혜영, "2010-2011년 부산 경남 지역에서 급성 하기도 감염으로 입원한 소아의 호흡기 바이러스 임상 양상", Allergy Asthma & Respiratory Disease, 22(3), pp.265~272 (2012), 대한 소아알레르기 호흡기학회
  13. 박규희, "2008-2011년 한국 수도권에서 60개월 미만 하기도 감염 소아에 서의 respiratory syncytial virus 감염의 계절적 변동", Neonatal medicine, 19(4), pp.195~203 (2012), 대한신생아학회
  14. Jung HD, "Prevalence of respiratory viruses in patients causing acute respiratory infections, 2013", Public Health Wkly Rep, 7, pp.805~812 (2014)
  15. Su-Jeong Hwang, "Characteristics of Respiratory Syncytial Virus isolated from Acute Respiratory Infectious Disease in Busan", Journal of Bacteriology and Virology, 46(3), pp.173~180 (2016), 대한미생물학회[DOI]
  16. Jung HD, "Prevalence of respiratory viruses in patients with acute respiratory infections, 2014", Public Health Wkly Rep, 9, pp.26~36 (2016)
  17. 강수영, "소아에서 발생한 Human metapneumovirus 감염의 임상-역학적특징: Respiratory Syncytial Virus A and B 감염과의 비교", Pediatric Infection and Vaccine, 20(3), pp.168~177 (2013), 대한소아감염학회
  18. McConnochie KM, "Variation in severity of respiratory syncytial virus infections with subtype", J Pediatr, 117(1 Pt 1), pp.52~62 (1990)
  19. Martinello RA, "Correlation between respiratory syncytial virus genotype and severity of illness", J Infect Dis, 186, pp.839~842 (2002)
  20. Gilca R, "Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons", J Infect Dis, 193, pp.54~58 (2006)
  21. Hendry RM, "Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus", J Infect Dis, 157, pp.640~647 (1988)
  22. Taylor CE, "Comparative virulence of respiratory syncytial virus subgroups A and B", Lancet, 1, pp.777~778 (1989)
  23. Hall CB, "Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children", J Infect Dis, 162, pp.1283~1290 (1990)
  24. Devincenzo JP, "Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load", Pediatr Res, 56, pp.914~917 (2004)
  25. 신승한, "신생아기와 조기 영아기에 발생한 기계환기요법이 필요했던 중증respiratory syncytial virus 감염의 임상적 특성", Clinical and Experimental Pediatrics, 51(4), pp.372~376 (2008), 대한소아청소년과학회
  26. Fodha I, "Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity", J Med Virol, 79, pp.1951~1958 (2007)
  27. 박선희, "신생아집중치료실에서의 급성 호흡기 감염-바이러스의 검출 및 respiratory syncytial virus 감염의 임상적 특징", Neonatal medicine, 16(2), pp.182~189 (2009), 대한신생아학회
  28. Jung YJ, "Comparison of the AdvanSure real-time RT-PCR and Seeplex RV12 ACE assay for the detection of respiratory viruses", J Virol Methods, 224, pp.42~46 (2015)
  29. Olabarrieta I, "Hospital admission due to respiratory viral infections in moderate preterm, late preterm and term infants during their first year of life", Allergol Immunopathol (Madr), 43, pp.469~473 (2015)
  30. 민성주, "Respiratory syncytial virus로 인한 급성 하기도 감염 입원 환자에서 Palivizumab 예방요법 유무에 따른 비교 분석", Pediatric Infection and Vaccine, 18(2), pp.154~162 (2011), 대한소아감염학회
  31. Hall CB, "Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended", Clin Infect Dis, 31, pp.590~596 (2000)
  32. Garcia CG, "Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis", Pediatrics, 126, pp.e1453~e1460 (2010)
  33. Hall CB, "Respiratory syncytial virus infections in infants: quantitation and duration of shedding", J Pediatr, 89, pp.11~15 (1976)
  34. "Status of postpartum care centers nationwide" (2016)[URL]
  35. Lee SS, "The 2015 national survey on fertility and family health and welfare" (2015), Korea Institute for Health and Social Affairs
  36. 홍승지, "경북 단일 산후조리원에서 발생한 RSV 집단 감염", Perinatology, 27(1), pp.60~66 (2016), 대한주산의학회

관련 논문AI추천

이 간행물의 다른 논문 (8건)